Serum creatinine is one of the most commonly requested laboratory tests used to assess kidney function. It is a waste product produced during the normal breakdown of creatine phosphate in skeletal muscle and is released into the bloodstream at a relatively constant rate. Healthy kidneys filter creatinine from the blood and excrete it in the urine, making serum creatinine a valuable indicator of renal function.
Because creatinine production is closely related to muscle mass, serum creatinine concentrations vary between individuals based on factors such as age, biological sex, body size, and overall muscle mass. For this reason, serum creatinine should rarely be interpreted in isolation. Instead, healthcare professionals typically use it alongside validated clinical equations that estimate kidney function more accurately.
One of the most common applications of serum creatinine is the estimation of glomerular filtration rate (eGFR), which provides an assessment of overall kidney function. Serum creatinine is also a key component of the Cockcroft–Gault equation used to estimate creatinine clearance (CrCl), particularly when determining appropriate medication dosing in patients with impaired renal function.
Elevated serum creatinine levels often suggest reduced kidney function, although the cause may be acute or chronic. Common causes include acute kidney injury (AKI), chronic kidney disease (CKD), dehydration, urinary tract obstruction, and reduced renal blood flow. Certain medications and increased muscle mass may also raise serum creatinine without indicating intrinsic kidney disease.
Conversely, low serum creatinine levels are generally less clinically significant but may occur in individuals with reduced muscle mass, advanced age, malnutrition, pregnancy, or chronic illness. Interpretation should always take account of the patient’s clinical history and overall condition.
When assessing renal function, healthcare professionals often consider serum creatinine alongside other laboratory measurements, including blood urea, electrolytes, cystatin C where available, and urine testing. Trends over time are frequently more informative than a single result, particularly when monitoring patients with chronic kidney disease or suspected acute kidney injury.
Serum creatinine forms an essential part of numerous clinical calculators used throughout healthcare. In addition to eGFR and Cockcroft–Gault calculations, it contributes to medication dosing decisions, chronic kidney disease staging, and the assessment of patients before diagnostic imaging or procedures involving contrast agents.
At MediCalc, serum creatinine is incorporated into validated clinical calculators based on recognised medical literature and established clinical practice. These tools are designed to support healthcare professionals by providing accurate calculations that complement comprehensive clinical assessment and professional judgement.
Understanding serum creatinine and its relationship with kidney function enables clinicians to detect renal impairment, monitor disease progression, optimise medication dosing, and support safer, evidence-based patient care.